Duchenne muscular dystrophy trials in Canada

5 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping

  Where

  London

  Age

  7 years to 16 years

  People

  70 worldwide

  Run by

  Avidity Biosciences, Inc.

  See details and how to joinNCT07587242
• Phase 3Taking people
  A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)

  Where

  Calgary, Toronto, Vancouver

  Age

  7 years to 11 years

  People

  80 worldwide

  Run by

  Solid Biosciences Inc.

  See details and how to joinNCT07160634 · EU 2025-522949-22-00
• Phase 3Taking people
  Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy

  Where

  London, Ottawa, Toronto, Vancouver

  Age

  9 years to 17 years

  People

  138 worldwide

  Run by

  Italfarmaco

  See details and how to joinNCT05933057 · EU 2023-503521-19-00
• Phase 1/2Taking people
  A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)

  Where

  Toronto

  Age

  0 years to 17 years

  People

  60 worldwide

  Run by

  Solid Biosciences Inc.

  See details and how to joinNCT06138639 · EU 2024-514501-57-00
• Phase 2/3Taking people
  Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study

  Where

  Calgary, Toronto, Vancouver

  Age

  7 years and over

  People

  206 worldwide

  Run by

  Italfarmaco

  See details and how to joinNCT03373968